Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Spratlin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancers|February 24, 2024
Individual Survival Distributions Generated by Multi-Task Logistic Regression Yield a New Perspective on Molecular and Clinical Prognostic Factors in Gastric AdenocarcinomaDaniel Skubleny, Jennifer Spratlin, Sunita Ghosh, et al.
American Journal of Clinical Oncology|November 7, 2019
Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic CancerErica S Tsang, Jennifer Spratlin, Winson Y Cheung, et al.
Biomedicines|January 21, 2023
Murine and Human Gastric Tissue Establishes Organoids after 48 Hours of Cold Ischemia Time during ShipmentDaniel Skubleny, Saurabh Garg, Jim Wickware, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell LymphomaRandeep Sangha, Neal M Davies, Afshin Namdar, et al.
CMAJ Open|March 2, 2019
Effect of proximity to specialty care on outcomes for biliary cancers: a population-based retrospective cohort studyYuan Xu, Sue Steckle, Arthur Lui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinomaJennifer Spratlin, Randeep Sangha, Darryl Glubrecht, et al.
Investigational New Drugs|June 5, 2024
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomasRandeep Sangha, Rahima Jamal, Jennifer Spratlin, et al.
Investigational New Drugs|March 13, 2015
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumorsQuincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 7, 2020
Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patientsRan Yang, Moftah Younis, Kurian Joseph, et al.
Lung Cancer (Amsterdam, Netherlands)|November 23, 2006
Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancerLee W Jones, Neil D Eves, John R Mackey, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancers|February 24, 2024
Individual Survival Distributions Generated by Multi-Task Logistic Regression Yield a New Perspective on Molecular and Clinical Prognostic Factors in Gastric AdenocarcinomaDaniel Skubleny, Jennifer Spratlin, Sunita Ghosh, et al.
American Journal of Clinical Oncology|November 7, 2019
Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic CancerErica S Tsang, Jennifer Spratlin, Winson Y Cheung, et al.
Biomedicines|January 21, 2023
Murine and Human Gastric Tissue Establishes Organoids after 48 Hours of Cold Ischemia Time during ShipmentDaniel Skubleny, Saurabh Garg, Jim Wickware, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell LymphomaRandeep Sangha, Neal M Davies, Afshin Namdar, et al.
CMAJ Open|March 2, 2019
Effect of proximity to specialty care on outcomes for biliary cancers: a population-based retrospective cohort studyYuan Xu, Sue Steckle, Arthur Lui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinomaJennifer Spratlin, Randeep Sangha, Darryl Glubrecht, et al.
Investigational New Drugs|June 5, 2024
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomasRandeep Sangha, Rahima Jamal, Jennifer Spratlin, et al.
Investigational New Drugs|March 13, 2015
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumorsQuincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 7, 2020
Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patientsRan Yang, Moftah Younis, Kurian Joseph, et al.
Lung Cancer (Amsterdam, Netherlands)|November 23, 2006
Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancerLee W Jones, Neil D Eves, John R Mackey, et al.
Pageof 3